On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - $157.14 /
+14.81 (+10.41%) - 05/02/22
- Zscaler appoints Castle as Chief People Officer
- 04/13/22
- Synchronoss appoints Stanley Lowe as chief information security officer
- 12/22/21
- Zscaler officer Rajic sells $7.9M in company shares
- 12/20/21
- Zscaler CFO sells $4.47M in common stock
- 05/24/22
- Wendy's board to 'carefully review any proposal submitted by Trian Partners'
- 05/24/22
- Wendy's up 15% to $18.70 following Trian 13D/A filing on potential transaction
- 05/24/22
- Wendy's shareholder Trian to explore potential transaction
- 05/14/22
- Trian exits Comcast position, increases stake in Invesco
- $152.90 /
-15.16 (-9.02%) - 05/26/22
- Workday drops 7% to $155.50 after Q1 EPS misses estimates
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- 02/28/22
- Workday sees FY23 subscription revenue at $5.53B-$5.55B, up 22% y/y
- 02/14/22
- Lone Pine takes stakes in Mastercard, Visa, exits Twitter, Meta Platforms
- 05/16/22
- Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet
- 05/12/22
- UnitedHealth selected by State of Missouri to serve Medicaid beneficiaries
- 04/26/22
- Change says UnitedHealth to sell ClaimsXten for $2.2B if deal closes
- $414.47 /
+36.855 (+9.76%) - 05/26/22
- Ulta Beauty jumps 7.6% to $406.50 after Q1 earnings beat and guidance raise
- 05/19/22
- Ulta Beauty launches retail media network UB Media
- 03/28/22
- PayPal broadens access to post purchase services for merchants
- 03/11/22
- Ulta Beauty approves new $2B share repurchase authorization
- 05/27/22
- Twitter board does not accept resignation of Silver Lake's Egon Durban
- 05/25/22
- Twitter up 9% after Elon Musk files amended 13D related to takeover agreement
- 05/25/22
- Musk commits to provide additional $6.25B in equity financing for Twitter deal
- 05/20/22
- Elon Musk: We will never surrender/settle an unjust case against us
- $752.74 /
+45.62 (+6.45%) - 05/24/22
- Cathie Wood's ARK Investment bought 26.1K shares of Tesla today
- 05/23/22
- Cathie Wood's ARK Investment bought 15.9K shares of Tesla today
- 05/20/22
- Musk denies he sexually harassed flight attendant on private jet
- 05/10/22
- SoFi Technologies off lows after resumption, remains down 13%
- 05/10/22
- SoFi Technologies trading resumes
- 05/10/22
- SoFi Technologies to resume trading at 2:10 pm ET
- 05/10/22
- SoFi Technologies CEO says 'off to a great start' standing up bank
- 03/24/22
- Sallie Mae appoints William Wolf as CPO
- 01/26/22
- Sallie Mae board approves new $1.25B share repurchase program
- 01/26/22
- Sallie Mae to acquire Nitro College, terms not disclosed
- 05/19/22
- Siga Technologies receives FDA approval for IV formulation of TPOXX
- 05/12/22
- Siga Technologies awarded $7.5M Department of Defense contract
- 05/05/22
- Siga Technologies announces special dividend of 45c per share
- 03/02/22
- Siga Technologies announces start of TPOXX PEP clinical trials
- 05/26/22
- PMV Pharmaceuticals: Lead program, PC14586 accepted as oral presentation at ASCO
- 04/27/22
- PMV Pharmaceuticals to present initial PC14586 Phase 1 data at ASCO
- 04/21/22
- Navient announces Lehman to leave board of directors
- 04/18/22
- Navient, Sherborne Investors enter cooperation agreement
- 04/01/22
- Navient sponsors USS Delaware commissioning commemoration event
- 02/14/22
- Cooperman's Omega added Mirion, Discovery and Gan in Q4
- 05/09/22
- Marvell to acquire Tanzanite in an all-cash transaction
- 04/20/22
- Marvell appoints Sara Andrews to board of directors
- 04/14/22
- Worldwide semiconductor revenue grew 26% in 2021, Gartner says
- 03/14/22
- Marvell CEO: The company is performing extremely well
- $38.54 /
-19.89 (-34.04%) - 05/27/22
- Mirati Therapeutics trading resumes
- 05/27/22
- Mirati Therapeutics trading halted, volatility trading pause
- 05/26/22
- Mirati Therapeutics says disease control rate was 80% in study
- 05/19/22
- Mirati Therapeutics submits adagrasib MAA to EMA
- 05/26/22
- Medtronic: Q1 EPS guidance includes FX headwind of about 5c
- 05/26/22
- Medtronic: Procedure volumes in most markets reached pre-Covid levels by Q4E
- 05/26/22
- Medtronic sees 'strong' improvement in 2H23, pipeline 'robust'
- 05/26/22
- Medtronic: Parts of quarter played out as anticipated, but unexpected challenges
- 05/26/22
- Macy's rises 14.2%
- 05/26/22
- Macy's rises 16.9%
- 05/26/22
- Macy's jumps 12.5% to $21.61 after Q1 earnings beat
- 05/26/22
- Macy's reports Q1 digital sales up 2% y/y and 34% q/q
- 05/20/22
- iQIYI set to release 213 new pieces of content
- 04/25/22
- iQIYI launches third set of digital collectibles
- 04/01/22
- iQIYI to upgrade collaboration model for online film distribution
- 03/31/22
- iQIYI provides update on status under HFCAA
IOVA Iovance Biotherapeutics - 05/26/22
- Iovance announces clinical data for lifileucel in advanced melanoma
- 04/05/22
- Iovance Biotherapeutics provides regulatory update on lifileucel
- 03/15/22
- Iovance Biotherapeutics announces FDA allows IOV-4001 IND to proceed
- 01/10/22
- Iovance appoints Raj Puri as EVP, regulatory strategy, translational medicine
- 05/27/22
- Hibbett drops 7% to $47.50 after Q1 results miss estimates
- 05/27/22
- Hibbett CEO says 'supply chain disruption has improved, inventory strong'
- 03/04/22
- Hibbett reports Q4 SSS up 20.7% on two-year basis
- 03/04/22
- Hibbett sees FY23 CapEx $60M-$70M
- 05/27/22
- Gap falls -14.2%
- 05/27/22
- Gap trading resumes
- 05/27/22
- Gap trading halted, volatility trading pause
- 05/26/22
- Gap falls 14% to $9.60 after Q1 earnings miss and guidance cut
- 05/27/22
- Farfetch rises 22.8%
- 05/27/22
- Farfetch rises 14.7%
- 05/26/22
- Farfetch sees FY22 Digital GMV up 5%-10% and Brand Platform GMV up 10%-15%
- 04/05/22
- Farfetch, Neiman Marcus Group announce global strategic partnership
- 05/23/22
- Didi to proceed with delisting of shares from NYSE
- 05/16/22
- Paulson exits Cerner, boosts Didi in Q1
- 04/17/22
- DiDi to hold shareholder meeting on May 23 to vote on U.S. delisting plans
- 03/25/22
- Didi falls -13.4%
- 05/27/22
- Dell Technologies rises 14.2%
- 05/27/22
- Dell Technologies rises 18.1%
- 05/26/22
- Dell Technologies jumps 7% to $47.02 after Q1 results beat estimates
- 05/26/22
- Dell Technologies ended Q1 with performance obligations of $42B
- 05/04/22
- Costco reports April sales of $17.33B, up 13.9%
- 04/13/22
- Costco increases quarterly cash dividend to 90c per share
- 04/06/22
- Costco reports March sales of $21.61B, up 18.7%
- 03/08/22
- Jones Soda's Fountain Syrup now sold at Costco Business Centers
- 01/28/22
- Boot Barn CEO: Plenty of opportunities to grow the business
- 01/27/22
- Boot Barn sees FY22 CapEx $41M-$43M
- 05/27/22
- Big Lots falls -10.3%
- 05/27/22
- Big Lots falls -16.0%
- 05/27/22
- Big Lots falls -11.7%
- 05/27/22
- Big Lots drops 18% to $25.00 after Q1 results miss estimates
- 05/27/22 UBS
- Gap price target lowered to $11 from $14 at UBS
- 05/27/22 Deutsche Bank
- Gap price target lowered to $12 from $17 at Deutsche Bank
- 05/27/22 Wells Fargo
- Gap price target lowered to $16 from $20 at Wells Fargo
- 05/27/22 Baird
- Gap price target lowered to $11 from $14 at Baird
- $152.90 /
-15.16 (-9.02%) - 05/27/22 DA Davidson
- Workday price target lowered to $220 from $250 at DA Davidson
- 05/27/22 Stifel
- Workday price target lowered to $220 from $275 at Stifel
- 05/27/22 BMO Capital
- Workday price target lowered to $239 from $249 at BMO Capital
- 05/27/22 Needham
- Workday price target lowered to $200 from $300 at Needham
- $414.47 /
+36.855 (+9.76%) - 05/27/22 DA Davidson
- Ulta Beauty price target raised to $465 from $450 at DA Davidson
- 05/27/22 Oppenheimer
- Ulta Beauty price target raised to $485 from $470 at Oppenheimer
- 05/27/22 Jefferies
- Jefferies upgrades Ulta Beauty to Buy after 'signal we'd been waiting for'
- 05/27/22 Baird
- Ulta Beauty price target raised to $490 from $450 at Baird
- 05/27/22 BofA
- Dell Technologies price target raised to $67 from $65 at BofA
- 05/27/22 Morgan Stanley
- Dell Technologies price target lowered to $56 from $60 at Morgan Stanley
- 05/27/22 Deutsche Bank
- Dell Technologies price target lowered to $60 from $65 at Deutsche Bank
- 05/25/22 Evercore ISI
- Dell Technologies added to 'Tactical Outperform' list at Evercore ISI
- 05/27/22 Truist
- Costco price target raised to $543 from $503 at Truist
- 05/27/22 Baird
- Costco price target lowered to $560 from $600 at Baird
- 05/27/22 Credit Suisse
- Costco price target lowered to $550 from $570 at Credit Suisse
- 05/27/22 Loop Capital
- Costco price target lowered to $610 from $650 at Loop Capital
- 05/27/22 Baird
- Boot Barn upgraded to Outperform from Neutral at Baird
- 05/11/22 Craig-Hallum
- Boot Barn price target lowered to $145 from $162 at Craig-Hallum
- 05/11/22 JPMorgan
- Boot Barn added to Analyst Focus List at JPMorgan
- 05/06/22 Piper Sandler
- Boot Barn upgraded to Overweight from Neutral at Piper Sandler
- $157.14 /
+14.81 (+10.41%) - 05/27/22 Cowen
- Zscaler price target lowered to $194 from $405 at Cowen
- 05/27/22 Canaccord
- Zscaler price target lowered to $210 from $320 at Canaccord
- 05/27/22 BMO Capital
- Zscaler price target lowered to $172 from $270 at BMO Capital
- 05/27/22 Baird
- Zscaler price target lowered to $200 from $300 at Baird
- 05/27/22 BMO Capital
- Marvell price target lowered to $82 from $98 at BMO Capital
- 05/27/22 Needham
- Marvell price target lowered to $75 from $105 at Needham
- 05/27/22 BofA
- Marvell price target lowered to $90 from $100 at BofA
- 05/27/22 Cowen
- Marvell price target lowered to $85 from $100 at Cowen
- 05/25/22 Deutsche Bank
- Big Lots price target lowered to $31 from $44 at Deutsche Bank
- 05/24/22 BofA
- Big Lots price target lowered to $25 from $31 at BofA
- 05/20/22 Piper Sandler
- Big Lots price target lowered to $29 from $34 at Piper Sandler
- 05/10/22 JPMorgan
- Big Lots price target lowered to $25 from $31 at JPMorgan
- 05/20/22 Benchmark
- Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
- 05/27/22 Deutsche Bank
- Macy's price target lowered to $29 from $34 at Deutsche Bank
- 05/27/22 Citi
- Macy's price target lowered to $23 from $25 at Citi
- 05/27/22 Morgan Stanley
- Macy's upgraded to Equal Weight from Underweight at Morgan Stanley
- 05/16/22 JPMorgan
- Macy's price target lowered to $30 from $33 at JPMorgan
- 05/27/22 Benchmark
- iQIYI upgraded to Buy from Hold at Benchmark
- 05/26/22 Citi
- Citi upgrades iQIYI on earlier than expected profitability
- 05/26/22 Citi
- iQIYI upgraded to Buy from Neutral at Citi
- 05/16/22 JPMorgan
- iQIYI upgraded to Overweight from Underweight at JPMorgan
- 05/26/22 Bernstein
- UnitedHealth downgraded to Market Perform at Bernstein on valuation
- 05/26/22 Bernstein
- UnitedHealth downgraded to Market Perform from Outperform at Bernstein
- 05/11/22 Citi
- MultiPlan price target raised to $6.50 from $6 at Citi
- 04/26/22 Piper Sandler
- Piper 'incrementally confident' Change, UNH will prevail in August
- 05/27/22 RBC Capital
- Medtronic price target lowered to $122 from $135 at RBC Capital
- 05/27/22 Cowen
- Medtronic price target lowered to $117 from $125 at Cowen
- 05/27/22 Needham
- Medtronic downgraded to Hold at Needham on slowing revenue growth
- 05/27/22 Deutsche Bank
- Medtronic price target lowered to $121 from $149 at Deutsche Bank
- 05/18/22 RBC Capital
- Reckitt Benckiser upgraded to Outperform from Sector Perform at RBC Capital
- 05/09/22 Morgan Stanley
- Reckitt Benckiser price target raised to 7,100 GBp at Morgan Stanley
- 05/03/22 RBC Capital
- Reckitt Benckiser price target raised to 5,900 GBp at RBC Capital
- 05/03/22 Barclays
- Reckitt Benckiser price target raised to 9,300 GBp from 9,100 GBp at Barclays
- 04/11/22 JPMorgan
- Navient cut to Underweight at JPMorgan on student lending normalization delay
- 04/11/22 JPMorgan
- Navient downgraded to Underweight from Neutral at JPMorgan
- 03/31/22 Compass Point
- Navient downgraded to Neutral from Buy at Compass Point
- 01/27/22 JPMorgan
- Navient price target lowered to $21 from $23 at JPMorgan
- 05/17/22 Mizuho
- SoFi Technologies price target lowered to $9 from $14 at Mizuho
- 05/16/22 Piper Sandler
- Piper upgrades SoFi to buy ahead of 'significant' earnings ramp
- 05/16/22 Piper Sandler
- SoFi Technologies upgraded to Overweight from Neutral at Piper Sandler
- 05/12/22 Citi
- SoFi Technologies price target lowered to $11 from $17 at Citi
- 01/13/22 Credit Suisse
- Nelnet downgraded to Neutral from Outperform at Credit Suisse
- 05/02/22 Citi
- Sallie Mae price target lowered to $21 from $26 at Citi
- 04/18/22 Stephens
- Sallie Mae downgraded to Equal Weight from Overweight at Stephens
- 01/10/22 Barclays
- Sallie Mae price target raised to $27 from $25 at Barclays
- 07/22/21 Stephens
- Stephens 'surprised' by Sallie Mae stock underperformance, ups target to $23
- 03/16/22 US Tiger
- China Internet sector upgraded to Outperform from Neutral at US Tiger
- 02/14/22 Bernstein
- Didi initiated with an Outperform at Bernstein
- 07/28/21 Alliance Global Partners
- Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
- 07/28/21 Alliance Global Partners
- iClick Interactive price target lowered to $15 from $21 at Alliance Global
- 05/24/22 Jefferies
- Twitter price target lowered to $40 from $48 at Jefferies
- 05/24/22 Wedbush
- More fireworks expected heading into Twitter shareholder meeting, says Wedbush
- 05/24/22 KeyBanc
- Snap price target lowered to $27 from $45 at KeyBanc
- 05/24/22 Bernstein
- Bernstein says Tesla-Twitter saga far from over, discusses funding requirements
- $752.74 /
+45.62 (+6.45%) - 05/27/22 Credit Suisse
- Tesla pullback brings attractive entry point, says Credit Suisse
- 05/26/22 Jefferies
- Jefferies cuts Tesla price target on governance risk, challenging market
- 05/27/22 Wedbush
- Farfetch price target lowered to $8 from $16 at Wedbush
- 05/27/22 Morgan Stanley
- Farfetch price target lowered to $30 from $56 at Morgan Stanley
- 05/27/22 Wells Fargo
- Farfetch price target lowered to $25 from $35 at Wells Fargo
- 05/27/22 BTIG
- Farfetch price target lowered to $16 from $26 at BTIG
- 03/02/22 Oppenheimer
- Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target
- 03/02/22 Oppenheimer
- PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
- 09/22/21 Goldman Sachs
- PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
- 08/19/21 Oppenheimer
- PMV Pharmaceuticals initiated with a Perform at Oppenheimer
IOVA Iovance Biotherapeutics - 05/27/22 H.C. Wainwright
- Iovance Biotherapeutics 'close to the finish line,' says H.C. Wainwright
- 05/27/22 Oppenheimer
- Iovance Biotherapeutics price target lowered to $27 from $31 at Oppenheimer
- 05/27/22 Stifel
- Iovance Biotherapeutics after-hours stock reaction seems 'overdone,' says Stifel
- 05/27/22 Chardan
- Iovance Biotherapeutics price target lowered to $31 from $44 at Chardan
- $38.54 /
-19.89 (-34.04%) - 05/27/22 Stifel
- Mirati Therapeutics after-hours move lower 'overdone,' says Stifel
- 05/20/22 Guggenheim
- Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
- 05/20/22 Guggenheim
- Mirati Therapeutics upgraded to Buy from Neutral at Guggenheim
- 05/05/22 Stifel
- ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
- 05/25/22 MKM Partners
- Wendy's may see more 'value unlocks' from strategic options, says MKM Partners
- 05/25/22 Wedbush
- Wedbush remains bullish on Wendy's, not surprised by Trian news
- 05/25/22 Stifel
- Wendy's deal in 'low-$20 range' would be 'feasible,' says Stifel
- 05/12/22 Truist
- Wendy's price target lowered to $27 from $29 at Truist
- 03/07/22 Benchmark
- Hibbett price target lowered to $80 from $125 at Benchmark
- 02/22/22 Monness Crespi
- Hibbett price target lowered to $80 from $120 at Monness Crespi
- 02/21/22 Baird
- Hibbett price target lowered to $75 from $100 at Baird
- 12/06/21
- Fly Intel: Top five analyst upgrades
- $157.14 /
+14.81 (+10.41%) - 05/26/22
- Zscaler sees FY22 EPS 64c-65c, consensus $55c
- 05/26/22
- Zscaler sees Q4 EPS 20c-22c, consensus 17c
- 05/26/22
- Zscaler reports Q3 EPS 17c, consensus 11c
- 05/26/22
- Wendy's affirms FY22 EPS view at 82c-86c, consensus 83c, postpones Investor Day
- 05/11/22
- Wendy's backs FY22 adjusted EPS view 82c-86c, consensus 87c
- 05/11/22
- Wendy's reports Q1 adjusted EPS 17c, consensus 18c
- 05/10/22
- Notable companies reporting before tomorrow's open
- $152.90 /
-15.16 (-9.02%) - 05/26/22
- Workday sees Q2 subscription revenue $1.353B-$1.355B
- 05/26/22
- Workday raises FY23 subscription revenue view to $5.537B-$5.557B
- 05/26/22
- Workday reports Q1 EPS 83c, consensus 86c
- 04/14/22
- UnitedHealth raises FY22 adjusted EPS view to $21.20-$21.70 from $21.10-$21.60
- 04/14/22
- UnitedHealth reports Q1 adjusted EPS $5.49, consensus $5.38
- 04/13/22
- Notable companies reporting before tomorrow's open
- $414.47 /
+36.855 (+9.76%) - 05/26/22
- Ulta Beauty raises FY22 EPS view to $19.20-$20.10 from $18.20-$18.70
- 05/26/22
- Ulta Beauty reports Q1 EPS $6.30, consensus $4.46
- 03/10/22
- Ulta Beauty sees FY2 EPS $18.20-$18.70, consensus $17.84
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 04/28/22
- Twitter reports Q1 EPS 90c, consensus 3c
- 02/10/22
- Twitter expects FY22 revenue growth in low to mid 20's range
- 02/10/22
- Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B
- $752.74 /
+45.62 (+6.45%) - 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 01/26/22
- Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26
- 01/26/22
- Notable companies reporting after market close
- 05/10/22
- SoFi Technologies sees FY22 adjusted revenue $1.505B-$1.51B, consensus $1.46B
- 05/10/22
- SoFi Technologies sees Q2 adjusted net revenue $330M-$340M, consensus $343.9M
- 05/10/22
- SoFi Technologies reports Q1 EPS (14c), consensus (14c)
- 05/10/22
- SoFi Technologies sees FY22 adjusted revenue $1.51B, Bloomberg says
- 04/27/22
- Sallie Mae sees FY22 core EPS $2.80-$3.00, consensus $2.95
- 04/27/22
- Sallie Mae reports Q1 core EPS 46c, consensus 82c
- 04/27/22
- Notable companies reporting after market close
- 01/26/22
- Sallie Mae reports Q4 core EPS $1.05, consensus 97c
- 03/03/22
- Siga Technologies reports Q 4EPS 98c versus 26c last year
- 05/10/22
- PMV Pharmaceuticals reports Q1 EPS (41c), consensus (40c)
- 03/01/22
- PMV Pharmaceuticals reports 2021 EPS ($1.28), consensus ($1.22)
- 04/27/22
- Navient raises FY22 EPS view to $3.20-$3.30 from $3.00-$3.15, consensus $3.03
- 04/26/22
- Navient reports Q1 adjusted EPS 90c, consensus 75c
- 04/26/22
- Notable companies reporting after market close
- 01/26/22
- Navient sees FY22 EPS $3.00-$3.15, consensus $3.12
- 05/26/22
- Marvell sees Q2 adjusted EPS 56c, +/- 3c per share, consensus 55c
- 05/26/22
- Marvell reports Q1 adjusted EPS 52c, consensus 51c
- 03/03/22
- Marvell sees Q1 adjusted EPS 51c +/- 3c, consensus 50c
- $38.54 /
-19.89 (-34.04%) - 02/28/22
- Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00)
- 02/28/22
- Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00)
- 05/26/22
- Medtronic sees Q1 organic revenue down 4.5%-5.5%, consensus $8.14B
- 05/26/22
- Medtronic sees Q1 EPS $1.10-$1.14, consensus $1.40
- 05/26/22
- Medtronic sees FY23 EPS $5.53-$5.65, consensus $5.82
- 05/26/22
- Medtronic reports Q4 EPS $1.52, consensus $1.56
- 05/26/22
- Macy's raises FY22 EPS view to $4.53-$4.95 from $4.13-$4.52, consensus $4.34
- 05/26/22
- Macy's reports Q1 EPS $1.08, consensus 82c
- 05/25/22
- Notable companies reporting before tomorrow's open
- 05/26/22
- iQIYI reports Q1 EPS 3c, consensus (11c)
- 03/01/22
- iQIYI reports Q4 EPS (20c), consensus (32c)
IOVA Iovance Biotherapeutics - 05/05/22
- Iovance Biotherapeutics reports Q1 EPS (58c), consensus (64c)
- 05/27/22
- Hibbett backs FY23 EPS view $9.75-$10.50, consensus $9.74
- 05/27/22
- Hibbett reports Q1 EPS $2.89, consensus $3.08
- 03/04/22
- Hibbett sees FY23 EPS $9.75-$10.50, consensus $9.85
- 03/04/22
- Hibbett reports Q4 EPS $1.25, consensus $1.35
- 05/26/22
- Gap cuts FY22 revenue view to down low-mid single digits from low single digits
- 05/26/22
- Gap cuts FY22 EPS view to 30c-60c from $1.85-$2.05
- 05/26/22
- Gap reports Q1 EPS (44c), consensus (13c)
- 05/26/22
- Notable companies reporting after market close
- 05/26/22
- Farfetch reports Q1 EPS (24c), consensus (28c)
- 02/24/22
- Farfetch reports Q4 adjusted EPS (3c), consensus (3c)
- 12/29/21
- Didi reports Q2 net loss (RMB 24.3B) vs. (RMB 63M) last year
- 05/26/22
- Dell Technologies reports Q1 adjusted EPS $1.84, consensus $1.39
- 02/24/22
- Dell Technologies reports Q4 adjusted EPS $1.72, consensus $1.95
- 02/24/22
- Notable companies reporting after market close
- 05/26/22
- Costco reports Q3 EPS $3.04, consensus $3.03
- 03/03/22
- Costco reports Q2 EPS $2.92, consensus $2.74
- 03/03/22
- Notable companies reporting after market close
- 05/10/22
- Boot Barn sees Q1 EPS $1.14, consensus $1.11
- 05/10/22
- Boot Barn sees FY23 EPS $6.41, consensus $5.56
- 05/10/22
- Boot Barn reports Q4 EPS $1.47, consensus $1.32
- 01/27/22
- Boot Barn reports Q3 EPS $2.23 ex-items, consensus $2.22
- 05/27/22
- Big Lots reports Q1 EPS (39c), consensus 93c
- 03/03/22
- Big Lots sees Q1 adjusted EPS $1.10-$1.20, consensus $1.28
- 03/03/22
- Big Lots reports Q4 adjusted EPS $1.75, consensus $1.89
- 01/10/22
- Big Lots sees Q4 performance at 'upper end' of expectations
|